Randox strengthen partnership with Sheffield United by agreeing to become naming right partner of the widely-acclaimed Sheffield United Academy
08th October 2021 – Randox strengthen partnership with Sheffield United by agreeing to become naming right partner of the widely-acclaimed Sheffield United Academy
Sheffield United have today announced a further strengthening of their principal partnership with Randox. The healthcare giants have agreed to become naming right partners of the widely-acclaimed Sheffield United Academy.
Located at Shirecliffe, it is the base of the men’s, women’s and academy teams. The facility, since its opening its doors in the early 2000s, has seen the likes of Kyle Walker, Harry Maguire, David Brooks, Dominic Calvert-Lewin and Aaron Ramsdale all progress through the academy ranks.
Established in 1982 in Northern Ireland, Randox is the largest healthcare diagnostics company from the UK and Ireland. In 2019 Randox manufactured over four billion tests and operated in over 145 countries. The company employs more than 2,500 staff, including more than 450 research scientists and engineers, with key facilities located in Co. Antrim and Co. Donegal.
Randox Managing Director Dr Peter FitzGerald CBE said: “We are very excited for the opportunity to extend our partnership by aligning Randox with the Sheffield United Academy. With almost 40 years of experience in the manufacture of world-leading medical diagnostics and comprehensive health check and sports science services, Randox is well positioned to assist in the development of the health, wellbeing and performance of these elite athletes. We look forward to working with the Academy and to lending our expertise to make further developments in cutting-edge sports science.”
United’s head of commercial, Paul Reeves, said: “This is a significant further investment from Randox and a long-term commitment to our next generation of players, both male and female. The academy plays an integral part within the club and it goes without question the rising importance of developing players of all ages to continue to compete on a global scale. We would like to thank Dr FitzGerald and his colleagues for their valued contribution.”
Paul added; “The newly-named Randox Health Academy has some exciting prospects on the horizon with the likes of Daniel Jebbison, Femi Seriki and Iliman Ndiaye all making their Premier League debuts at the end of the 20/21 season.”
Visit randoxhealth.com to find out more about their ground-breaking R&D, advanced health checks, and rapid COVID travel tests.
For press enquiries please contact Amy Millar in the Randox PR team on amy.millar@randox.com or 028 9442 2413
Want to know more?
Contact us or visit Randox Health.
Related COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TEST TO RELEASE
LABORATORY TOOLS
World Heart Day 2021
World Heart Day 2021
World Heart Day – Raising awareness of Cardiovascular Diseases
World Heart Day was established by the World Heart Federation in collaboration with the World Health Organization to raise awareness of cardiovascular diseases.
Cardiovascular disease (CVD) is the world’s number one killer, causing over 18.6 million deaths per year, according to the World Heart Federation. 85% of these deaths are due to coronary heart diseases (e.g. heart attacks) and cerebrovascular diseases (e.g. strokes) and mostly affect low-and middle-income countries.
What are cardiovascular diseases?
Cardiovascular diseases (CVDs) are a group of disorders relating to the heart and blood vessels and they include:
- coronary heart disease – disease of the blood vessels supplying the heart muscle
- cerebrovascular disease – disease of the blood vessels supplying the brain
- peripheral arterial disease – disease of blood vessels supplying the arms and legs
- rheumatic heart disease – damage to the heart muscle and heart valves from rheumatic fever, caused by streptococcal bacteria
- congenital heart disease – malformations of heart structure existing at birth
- deep vein thrombosis and pulmonary embolism – blood clots in the leg veins, which can dislodge and move to the heart and lungs
How can Randox help with these current global challenges
Cardiovascular disease, including heart disease, is easier to treat when detected early. Here at Randox, we utilise innovative diagnostic tests for early risk assessment capable of diagnosing disease at the earliest possible stages, because we understand that “prevention is better than cure”.
Randox Laboratories is a world leader in innovative diagnostics with 40 years’ experience and a leading provider of diagnostic reagents for the assessment of cardiovascular disease risk. Randox offer an extensive menu of cardiac biomarkers within the cardiology reagents panel including:
Risk Assessment
- CK-MB – useful in patients with chest pain; Creatine Kinase is an enzyme produced in many different types of cells, of which high levels indicate muscle trauma or damage.
- Myoglobin – a small protein which leaks out of muscle cells after injury, is also considered a biomarker for the detection of Myocardinal Infraction.
- Routine lipid tests to determine the patient’s cholesterol and triglyceride levels – HDL Cholesterol, LDL Cholesterol, Total Cholesterol and Triglycerides
- Independent risk assessment tests such as sdLDL Cholesterol and Lipoprotein(a) to determine any genetic factors which may increase their risk of CVD. Please note, this is necessary even for patients who have good cholesterol levels
- Secondary tests, such as High Sensitivity CRP, in addition to risk assessment markers and lipid evaluation – secondary tests are important in predicting future cardiac events of individuals with no previous history of CVD and those deemed healthy because of primary tests; approximately half of all heart attacks occur in patients classified as low risk. In addition, they can also be used to evaluate the risk of a recurrent cardiac event
- Homocysteine – elevated levels of homocysteine have been linked to various disease states including CVD. Extremely high levels are found in patients with homocystinuria, of which many suffer from early arteriosclerosis.
More information
If you are a clinician or lab interested in our Cardiology & Lipids Panel, we have a wealth of resources available:
Download our Reagents Brochure
Download our Cardiology & Lipid Testing Brochure
If you would like to get in touch with a Sales representative please email us reagents@randox.com
Want to know more about Randox?
Contact us or visit our homepage to view more.
Randox Signs Principal Partnership with Sheffield United FC
26th May 2021 – Randox Signs Principal Partnership with Sheffield United FC
Global innovative healthcare company and the UK’s largest COVID-19 PCR testing provider Randox is today pleased to announce that it has signed a three-year principle partnership agreement with Sheffield United. The partnership will commence in the 2021 /2022 season and will include both men’s and women’s first team. From next season both teams will wear the Randox logo on their jerseys.
Founded in 1982 in County Antrim by leading medical scientist, Dr. Peter FitzGerald CBE, Randox has been a pioneer in improving health and enhancing lives, worldwide. To achieve their goals the company is committed to an extensive research programme, including investing more than £300m in the development of its innovative biochip array programme to enable earlier, more accurate diagnosis. The company currently employs more than 2000 people of over 40 different nationalities.
Randox is a world leader in healthcare diagnostics; today more than 5% of the world’s population – in excess of 370 million people across 145 countries – receives medical diagnosis through use of Randox products each year. Over the past year, Randox has been at the forefront of the UK’s fight against COVID-19, and has significantly invested in its testing capacity meaning that it can now process over 500,000 tests per day, making it amongst the very largest COVID-19 laboratories in Europe. To date Randox having processed over 13 million COVID-19 PCR tests in the UK and now have comprehensive Covid-19 testing, logistics and customer services available to support overseas holidays and those undertaking international travel.
Randox has a proud history of supporting sports, and has been the Official Partner of the, the Grand National since 2017.
Dr. Peter FitzGerald CBE, Randox Chief Executive Officer, said;
“We are very excited about this partnership and the opportunity to align Randox with Sheffield United Football Club. Not only is Sheffield the birthplace of football, but it is also one of the fastest growing cities in developing sports science and medical technology which we are very keen to see how we can look to assist through our services. We are extremely proud to be the principal partner of the Blades and to be a part of the club’s progress in the years to come.”
For press enquiries please contact Amy Millar in the Randox PR team on amy.millar@randox.com or 028 9442 2413
Want to know more?
Contact us or visit Randox Health.
Related COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TEST TO RELEASE
LABORATORY TOOLS
Neonatal Bilirubin External Quality Assessment
The RIQAS Neonatal Bilirubin EQA programme has been designed to assess the performance of total and direct bilirubin assays with levels tailored to neonatal bilirubin testing.
- Lyophilised for enhanced stability
- Monthly reporting
- Human based serum
- Submit results and view reports online via RIQAS.net
- Rapid turnaround of reports allows for any necessary corrective actions to be taken with minimal disruption to laboratory output
- Cycle Starts – July 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9191 | 2 x (6x3ml) | Monthly (1 x 12 month cycle) | 2 | |
Parameter
- Direct Bilirubin
- Total Bilirubin
Please note, product availability may vary country to country.
The Silent Diabetes Pandemic: A Randox Reagents Blog
The Silent Pandemic
A striking statistic is that an estimated 4.2 million people die annually from Diabetes complications and it is anticipated it will be the seventh leading cause of death by 2030.
Type 2 diabetes mellitus (T2DM) has reached the status of ‘global pandemic’, a phrase we have become all too familiar with due to the current global Covid-19 pandemic, but one we now know not take for granted.
Diabetes is a chronic, potentially life-threatening disease and can cause a myriad of health complications which affect the feet, eyes, kidneys, and cardiovascular health.
Early detection and treatment of diabetes is key, particularly as many people with type 2 diabetes have no signs or symptoms but do have associated risk factors.
Randox is committed to raising awareness of preventative healthcare related to Diabetes through advancing diabetes testing capabilities, including diabetes diagnosis & monitoring, and monitoring of associated complications including; ketoacidosis, renal dysfunction, and metabolic status.
The Randox Diabetes testing panel consists of ten assays including niche and superior performance assays that are compatible with a wide range of clinical chemistry analyzers.
Contact Us
Find out more about the Randox diabetes reagents panel or alternatively you can contact us
reagents@randox.com | www.randox.com/diabetes-reagents
Product availability may vary from country to country. Some products may be for research use only. For more information on product application & availability, please contact your local Randox Representative
Diabetes Reagents Panel
Diagnosis & Monitoring
Fructosamine (Glycated Protein) (Enzymatic Method)
Ketoacidosis
Renal Dysfunction
Creatinine (Enzymatic & JAFFE Methods)
Metabolic Status
The Importance of Third-Party Controls #LABWEEK2021
In the clinical laboratory, Quality Control (QC) refers to the process of detecting analytical errors to ensure both the reliability and accuracy of patient test results. Poor performance can result in misdiagnosis, delayed/inappropriate treatment, increased costs and may even be potentially life threatening for the patient. Third party controls offer a better solution to ensure optimum performance and accuracy.
When the laboratory professional runs the QC material on their instrument, they can compare the obtained result with the expected result. If these values are comparable, then the laboratory professional can be confident that their instrument is reporting accurately. Essentially, QC is a ‘practice run’ to ensure the testing system is working correctly.
Benefits Of Using Third-Party Controls
Third party controls have been designed to deliver an independent, unbiased assessment of performance with any instrument or method helping you gain accreditation. Below are some of the key benefits of third party controls:
- Values assigned using a large number of independent laboratories ensuring statistically valid targets.
- Highly consolidated controls allow for space, time, and ultimately, cost savings.
- Boosted shelf life ensures continuity of supply and reduced costs
- Reduced preparation times by removing the need for multiple instrument controls
Importance Of Third-Party Controls In The Midst Of COVID-19
Quality Control is a hugely important part of laboratory quality. Around 70% of clinical decisions are made based on laboratory results, so it is plain to see how significant Quality Control practices can be in relation to global health care. Having faith in the performance of the Quality Control used within the lab, as well as benefits gained from highly consolidated controls, allow for space, time, and ultimately, cost savings. These benefits would prove highly beneficial for any laboratory operating in the fast-paced environment posed by the pandemic.
How Randox Can Help
Randox Acusera true third party quality controls offer complete test menu consolidation for laboratory Internal Quality Control. Providing accurate and reliable sample material and delivering results you can trust.
Find out more: https://www.randox.com/laboratory-quality-control-acusera/
Want to know more?
Contact us or visit our Acusera page to learn more.
Related Products
Serology Controls
Acusera Controls
RIQAS EQA
Resource Hub
Evidence Series Resource Hub
Banned substance furazolidone (AOZ) detected in shrimp at French border
14 April 2021: Banned substance furazolidone (AOZ) detected in shrimp at French border
As per an alert through RASFF – the Rapid Alert System for Food and Feed for the EU, shrimp imported from India has been rejected at the French border in March 2021 for containing a banned substance, known as furazolidone (AOZ). The shrimp product has since been destroyed and did not make it into the market for distribution.
Nitrofuran antibiotics, the parent compound of AOZ, were banned for use in animal food production in the EU in 1995 and 2009 in the US for its reported carcinogenic and mutagenic characteristics. However due to the drugs low cost and effectiveness in controlling disease it is still in use despite the ban.
Randox Food Diagnostics
Randox Food Diagnostics have developed a highly accurate and reliable immunoassay array which detects Nitrofuran residues including AOZ, AMOZ, AHD and SEM.
Available on the Evidence Investigator, our Antimicrobial Array III utilises our patented Biochip Array Technology which provides screening of up to 54 meat and seafood samples. The Evidence Investigator provides results for multiple drug residues and toxins in just 2.5 hours, saving the user both time and money compared to other screening and confirmatory methods.
Randox Food Diagnostics also provide a vast variety of ELISA kits to test for antibiotics in meat and seafood tissue, offering excellent cross-reactivity and unrivalled limits of detection. With results providing great correlation with confirmatory methods, we ensure that better science means safer food.
Want to know more?
For more information on tissue screening methods from Randox Food Diagnostics please visit the links below.
www.randoxfood.com/meat-and-seafood-analysis/
Alternatively contact us via email: info@randoxfooddiagnostics.com
Want to know more?
Contact us or visit our Randox Food Diagnostics website.
Related Products
Meat & Seafood
Milk
Honey
Wine
World Kidney Day 2021
World Kidney Day 2021
11th March 2021 is World Kidney Day, a worthy global campaign aimed at tackling “the hot topic everyone’s ignoring”.
Raising awareness of a disease that ‘one in every nine’ people worldwide suffer from, is something we take seriously.
Here at Randox, our vision is to improve healthcare worldwide and ensure patients across the globe have access to the latest advancements in clinical diagnostics to tackle diseases such as Chronic Kidney Disease.
This year World Kidney Day 2021 focuses on being able to live well with kidney disease. Many of us take for granted being able to live a normal life without the side effects such as fatigue, pain, depression, sleep problems etc. However Kidney disease can be huge challenge patients and those around them. The impacts of kidney disease can take a toll of day to day life and the ability to participate in activities such as work, travel, and socialising.
Kidney diseases are very common and can be harmful, but the good news is they are also very treatable!
Randox offer a comprehensive panel of kidney health tests, working to ensure timely and accurate diagnosis of kidney function problems to combat patient challenges early.
For example, low levels of albumin indicate signs of kidney damage in the early stages when diagnosis is key. Testing for albumin can identify individuals with diabetic nephropathy (damage to the kidneys caused by diabetes) around 10 years earlier than standard protein tests. The Randox albumin test can therefore enable preventative measures to be taken to reduce your risk of developing kidney disease.
With early diagnosis we can improve patient treatment outcomes and reduce the number of people across the world suffering with kidney health problems.
If you are a clinician or lab interested in running renal function assays, download our Reagents Brochure or email reagents@randox.com
If you want to find out the status of your own Kidney Health, book a health check with Randox Health today.
Want to know more about Randox?
Contact us or visit our homepage to view more.
Dog Food Recalled Due to Potentially Unsafe Levels of Aflatoxin
Dog Food Recalled Due to Potentially Unsafe Levels of Aflatoxin
The importance of screening food for toxins has been highlighted this month with the recent news that Midwestern Pet Foods Inc. have extended their product recall after reports that the pet food has potentially caused the deaths of 70 dogs due to containing possibly unsafe levels of aflatoxin.
The Food and Drug Administration said in a statement that it has been “aware of more than 70 dogs that have died and more than 80 that are sick after eating Sportmix pet food.”
Aflatoxins are mycotoxins produced by two species of Aspergillus, a fungus which is especially found in areas with hot and humid climates. Aflatoxins have a wide occurrence in feed and cereals, such as wheat, barley, rice and corn, which are used as ingredients in pet food. At high levels, aflatoxin can cause illness and death in animals.
Midwestern Pet Foods first announced a voluntary recall on Dec. 30, extending it last week. “There have been reports of illnesses and deaths in dogs associated with certain lots of products. No human illnesses have been reported,” the company said in a recall announcement. “Out of an abundance of caution, we have expanded this recall to cover all corn products containing pet foods with expiration dates prior to 07/09/22.”
Aflatoxin poisoning can display in animals with symptoms such as sluggishness, loss of appetite, vomiting, jaundice and diarrhoea.
The expanded recall includes “additional corn-containing lot codes of Sportmix, Pro Pac Originals, Splash, Sportstrail, and Nunn Better dry dog and cat foods” that were produced in its Oklahoma manufacturing plant. A full list of recalled products can be found here.
Randox Food Diagnostics
Randox provide solutions to the agricultural industry by having developed a range of screening platforms for toxins and drug residues within feed and cereals. Multiple mycotoxins can affect crops and drug residues can pass through to feed causing adverse health effects in both humans and animals.
Myco 9 facilitates the detection of up to 9 common mycotoxins from a single sample of cereal or cereal based feed, including aflatoxin B1/B2, aflatoxin G1/G2, deoxynivalenol, diacetoxyscirpenol, fumonisins, ochratoxin A, paxilline, T2 toxin & zearalenone.
For more information on the antibiotic screening arrays available contact us at: info@randoxfooddiagnostics.com
Want to know more?
Contact us or visit our Randox Food Diagnostics website.